GENERAL25 Sept 2026
Indegene share price jumps 5% to hit a 52-week high after Axis initiates coverage with a buy - Check target price | Stock Market News
Indegene shares rose about 5% on Friday, 25 September, hitting a 52-week high of ₹621.90. Axis Direct began covering the stock with a "buy" call and a ₹705 target, stating an 18% upside. Axis feels Indegene's mix of life-sciences knowledge and artificial intelligence tools gives it an edge. If you hold the stock, treat this as one brokerage's view, not a sure thing.
Key Statutory Highlights
- Axis Direct started coverage on Indegene with a "buy" recommendation and set a target price of ₹705.
- The stock opened at ₹595.05 and rose 4.8% to a 52-week high of ₹621.90 on the BSE.
- Indegene blends life-sciences domain expertise with proprietary technology, AI and data analytics for highly regulated workflows.
Actionable Advice for Taxpayers / Founders:If you are thinking of buying or selling Indegene, treat this as one brokerage's opinion only. Check the company's latest results and your own financial goals first, or speak to a registered investment adviser before acting.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: